IL4I1 and B-cell chronic lymphocytic leukemia: For example, IL4I1-generated Trp metabolites activate AHR and suppress adaptive immunity, correlating with poorer survival in glioblastoma patients and accelerated chronic lymphocytic leukemia (CLL) progression in mice [104].